Meyer Annika, Streichert Thomas
Institute of Clinical Chemistry, Faculty of Medicine and University Hospital, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Heliyon. 2024 May 16;10(10):e31411. doi: 10.1016/j.heliyon.2024.e31411. eCollection 2024 May 30.
Although diversity has been demonstrated to benefit research groups, women remain underrepresented in most scientific disciplines, including Laboratory Medicine and Clinical Chemistry. In order to promote diversity and equality in scientific communities, understanding the gender distribution of authorship is crucial.
This study included a total of 30,268 Web of Science-listed Clinical Chemistry and Laboratory Medicine publications from the United States of America, Canada, and the member countries of the European Federation of Clinical Chemistry and Laboratory Medicine from 2005 to 2022. In addition to the publication productivity of female and male authors over time, gender-specific publication characteristics and country-specific gender distributions of authorships were examined.
Overall, publications with female first authors increased by 49 % between 2005 and 2022, averaging 42 % female first authors. Eastern Europe (60 %) and Southern Europe (51 %) had particularly high proportions of female first authors. While female last authorship was the most predictive of female first authorship, with an odds ratio of 2.01 (95 % CI: 1.91-2.12, p < 0.001), only 27 % of last authors were female. Moreover, citation rate was not predictive of female first or last authorship.
Authorship in Clinical Chemistry and Laboratory Medicine is moving towards gender parity. This trend is more pronounced for first authors than for last authors. Further research into the citations of female authors in this discipline could be a starting point for increasing the visibility of women researchers in science. Moreover, geographical differences may provide opportunities for future research on gender parity across disciplines.
尽管已证明多样性对研究团队有益,但在包括检验医学和临床化学在内的大多数学科中,女性的代表性仍然不足。为了促进科学界的多样性和平等,了解作者署名的性别分布至关重要。
本研究纳入了2005年至2022年期间来自美国、加拿大以及欧洲临床化学和检验医学联合会成员国的30268篇被科学引文索引收录的临床化学和检验医学出版物。除了随时间推移的女性和男性作者的发表产出外,还研究了特定性别的发表特征以及特定国家的作者署名性别分布。
总体而言,2005年至2022年间,女性第一作者的出版物增加了49%,女性第一作者平均占42%。东欧(60%)和南欧(51%)的女性第一作者比例尤其高。虽然女性最后作者身份对女性第一作者身份的预测性最强,优势比为2.01(95%置信区间:1.91 - 2.12,p < 0.001),但只有27%的最后作者是女性。此外,引用率并不能预测女性第一或最后作者身份。
临床化学和检验医学领域的作者署名正在朝着性别平等发展。这一趋势在第一作者方面比最后作者更为明显。对该学科女性作者引用情况的进一步研究可能是提高女性研究人员在科学界知名度的一个起点。此外,地域差异可能为未来跨学科性别平等研究提供机会。